Literature DB >> 17726827

Resistance to viral infection of super p53 mice.

Cesar Munoz-Fontela1, Maria Angel Garcia, Isabel Garcia-Cao, Manuel Collado, Javier Arroyo, Mariano Esteban, Manuel Serrano, Carmen Rivas.   

Abstract

Induction of expression of the tumor suppressor p53 after interferon treatment has been recently demonstrated (Takaoka et al., 2003), suggesting an antiviral activity of the protein. In addition, a direct correlation between p53 levels and tumor resistance has been addressed by generating mice with an extra copy of p53 ('super p53' mice) (Garcia-Cao et al., 2002). Here, we show that vesicular stomatitis virus replication in mouse embryo fibroblasts derived from 'super p53' mice is impaired as a result of apoptosis induction via p53 activation. These findings unequivocally demonstrate an antiviral activity of p53, a process that may contribute to inhibit the spread of the virus in vivo.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 17726827     DOI: 10.1038/sj.onc.1208477

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  37 in total

1.  Crystal structure of SV40 large T-antigen bound to p53: interplay between a viral oncoprotein and a cellular tumor suppressor.

Authors:  Wayne Lilyestrom; Michael G Klein; Rongguang Zhang; Andrzej Joachimiak; Xiaojiang S Chen
Journal:  Genes Dev       Date:  2006-09-01       Impact factor: 11.361

2.  Antiviral action of the tumor suppressor ARF.

Authors:  María A García; Manuel Collado; César Muñoz-Fontela; Ander Matheu; Laura Marcos-Villar; Javier Arroyo; Mariano Esteban; Manuel Serrano; Carmen Rivas
Journal:  EMBO J       Date:  2006-09-07       Impact factor: 11.598

3.  Rb/E2F1 regulates the innate immune receptor Toll-like receptor 3 in epithelial cells.

Authors:  Manabu Taura; Mary Ann Suico; Kosuke Koyama; Kensei Komatsu; Rui Miyakita; Chizuru Matsumoto; Eriko Kudo; Ryusho Kariya; Hiroki Goto; Shunsuke Kitajima; Chiaki Takahashi; Tsuyoshi Shuto; Mitsuyoshi Nakao; Seiji Okada; Hirofumi Kai
Journal:  Mol Cell Biol       Date:  2012-02-06       Impact factor: 4.272

4.  SUMOylation of p53 mediates interferon activities.

Authors:  Laura Marcos-Villar; José V Pérez-Girón; Jéssica M Vilas; Atenea Soto; Carlos F de la Cruz-Hererra; Valerie Lang; Manuel Collado; Anxo Vidal; Manuel S Rodríguez; César Muñoz-Fontela; Carmen Rivas
Journal:  Cell Cycle       Date:  2013-08-05       Impact factor: 4.534

5.  Gallid Herpesvirus 1 Initiates Apoptosis in Uninfected Cells through Paracrine Repression of p53.

Authors:  Hai Li; Qi Gao; Yuhao Shao; Bangyao Sun; Fengjie Wang; Yangyang Qiao; Nana Wang; Shengwang Liu
Journal:  J Virol       Date:  2018-08-29       Impact factor: 5.103

6.  Vesicular stomatitis virus expressing tumor suppressor p53 is a highly attenuated, potent oncolytic agent.

Authors:  Joshua F Heiber; Glen N Barber
Journal:  J Virol       Date:  2011-08-03       Impact factor: 5.103

7.  p53 regulates CD46 expression and measles virus infection in myeloma cells.

Authors:  Anne Lok; Geraldine Descamps; Benoit Tessoulin; David Chiron; Marion Eveillard; Catherine Godon; Yannick Le Bris; Astrid Vabret; Celine Bellanger; Laurent Maillet; Sophie Barillé-Nion; Marc Gregoire; Jean-François Fonteneau; Steven Le Gouill; Philippe Moreau; Frederic Tangy; Martine Amiot; Agnes Moreau-Aubry; Catherine Pellat-Deceunynck
Journal:  Blood Adv       Date:  2018-12-11

Review 8.  Emerging roles of p53 and other tumour-suppressor genes in immune regulation.

Authors:  César Muñoz-Fontela; Anna Mandinova; Stuart A Aaronson; Sam W Lee
Journal:  Nat Rev Immunol       Date:  2016-09-26       Impact factor: 53.106

Review 9.  p53--a Jack of all trades but master of none.

Authors:  Melissa R Junttila; Gerard I Evan
Journal:  Nat Rev Cancer       Date:  2009-09-24       Impact factor: 60.716

Review 10.  Long story short: p53 mediates innate immunity.

Authors:  Jessica Miciak; Fred Bunz
Journal:  Biochim Biophys Acta       Date:  2016-03-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.